vimarsana.com

Page 12 - Bellerophon Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bellerophon Therapeutics (NASDAQ:BLPH) Coverage Initiated at StockNews com

StockNews.com initiated coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report issued on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other equities research analysts have also recently issued reports on the stock. Brookline Capital Management cut shares of Bellerophon Therapeutics from a buy rating to […]

Bellerophon Therapeutics (NASDAQ:BLPH) Earns Hold Rating from Analysts at StockNews com

Bellerophon Therapeutics (NASDAQ:BLPH) Earns Hold Rating from Analysts at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Stock Analysts New Coverage for August 26th (AAU, AEZS, AWX, BLPH, CALA, CANF, CCLP, CEQP, CIDM, CIR)

Stock Analysts’ new coverage for Saturday, August 26th: StockNews.com initiated coverage on shares of Almaden Minerals (NYSE:AAU). The firm issued a sell rating on the stock. StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS) (TSE:AEZ). StockNews.com issued a sell rating on the stock. StockNews.com assumed coverage on shares of Avalon (NYSE:AWX). The firm issued […]

StockNews com Begins Coverage on Bellerophon Therapeutics (NASDAQ:BLPH)

StockNews com Begins Coverage on Bellerophon Therapeutics (NASDAQ:BLPH)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Bellerophon Therapeutics (NASDAQ:BLPH) Research Coverage Started at StockNews com

StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note published on Friday. The firm issued a hold rating on the biotechnology company’s stock. A number of other equities analysts have also commented on BLPH. Laidlaw lowered Bellerophon Therapeutics from a buy rating to a hold rating in a […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.